Profile
Shengkan Victor Jin is the founder of Mito BioPharm LLC, where he currently holds the title of Chief Scientific Officer & Director.
Mito BioPharm LLC was founded in 2012.
Shengkan Jin active positions
Companies | Position | Start |
---|---|---|
Mito BioPharm LLC
Mito BioPharm LLC Pharmaceuticals: MajorHealth Technology Mito BioPharm LLC is an American pharmaceutical company that focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH) and type 2 diabetes. NAFLD is a range of conditions that start with fat accumulation in the liver and can progress to inflammation, fibrosis, cirrhosis, and even liver cancer. Mito BioPharm's drug discovery pipeline and intellectual property are aimed at addressing these conditions. | Founder | 2011-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Mito BioPharm LLC
Mito BioPharm LLC Pharmaceuticals: MajorHealth Technology Mito BioPharm LLC is an American pharmaceutical company that focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH) and type 2 diabetes. NAFLD is a range of conditions that start with fat accumulation in the liver and can progress to inflammation, fibrosis, cirrhosis, and even liver cancer. Mito BioPharm's drug discovery pipeline and intellectual property are aimed at addressing these conditions. | Health Technology |
- Stock Market
- Insiders
- Shengkan Jin